M. Lecart

Long‐term (3 years) prevention of trabecular postmenopausal bone loss with low‐dose intermittent nasal salmon calcitonin

J. Reginster, P. Franchimont, M. de Longueville, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

PREVENTION OF POSTMENOPAUSAL BONE LOSS BY TILUDRONATE

J. Reginster, P. Franchimont, J. Collette, 1989, The Lancet.

Treatment of Paget’s disease of bone with high doses of oral tiludronate given during a five-day course therapy

J. Reginster, P. Franchimont, N. Sarlet, 1990 .

Prevention of early postmenopausal bone loss by intranasal calcitonin - a controlled, randomised study lasting one year in normal women

J. Reginster, P. Franchimont, R. Deroisy, 1988 .